Martha Demski

Martha Demski

Director/Board Member at EQUILLIUM, INC.

Net worth: 144 317 $ as of 30/06/2026

73 year
Health Technology
Finance
Consumer Services

Profile

Ms. Martha J.
Demski
is an Independent Director at Alpha Teknova, Inc. and an Independent Director at Equillium, Inc. She is on the Board of Directors at Alpha Teknova, Inc. and Equillium, Inc. Ms. Demski was previously employed as an Independent Director by ADMA Biologics, Inc., an Independent Director by Neothetics, Inc., an Independent Director by Adamas Pharmaceuticals LLC, a Chief Financial Officer & Senior Vice President by Ajinomoto Althea, Inc., a Chief Operating & Financial Officer by Sidney Kimmel Cancer Center, a Chief Financial & Operating Officer by Sidney Kimmel Cancer Center, a Senior Vice President by US Trust, a Lead Independent Director by Chimerix, Inc., a Chief Financial Officer & Vice President by Vical, Inc., a Vice President by Bank of America Corp., and a Chief Operating & Financial Officer by Sidney Kimmel Cancer Center.
She received her undergraduate degree from Michigan State University and an MBA from The University of Chicago Booth School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/05/2026 23,799 ( 0.04% ) 76 157 $ 30/06/2026
01/06/2026 12,000 ( 0.02% ) 68 160 $ 30/06/2026

Martha Demski active positions

CompaniesPositionStart
EQUILLIUM, INC. Director/Board Member 01/09/2018
ALPHA TEKNOVA, INC. Director/Board Member 31/08/2023

Former positions of Martha Demski

CompaniesPositionEnd
CHIMERIX, INC. Chairman 01/08/2023
ADMA BIOLOGICS, INC. Director/Board Member 06/06/2023
ADAMAS PHARMACEUTICALS, INC. Director/Board Member 24/11/2021
Director/Board Member 01/01/2018
Director of Finance/CFO 01/05/2017
See the detail of Martha Demski's experience

Training of Martha Demski

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Finance

Health Technology

Health Technology

Consumer Services

Health Technology